Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

3.50
Data as of Aug 22
 -0.04 / -1.13%
Today’s Change
3.41
Today|||52-Week Range
5.93
-26.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$61.5M

Company Description

Alexza Pharmaceuticals, Inc. is a pharmaceutical company, which is focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system, or CNS, conditions. The company's product candidates are based on its proprietary technology, the Staccato system. Its lead product candidate is ADASUVE, which is being developed for the acute treatment of agitation in adults with schizophrenia or bipolar disorder. The company's other product candidates, which are in clinical stage includes AZ-007, Staccato nicotine, AZ-10, AZ-002 and AZ-002. It was formerly known as Alexza Molecular Delivery Corp. and changed its name to Alexza Pharmaceuticals, Inc. in July 2005. Alexza Pharmaceuticals was founded by Alejandro C. Zaffaroni on December 19, 2000 and is headquartered in Mountain View, CA.

Contact Information

Alexza Pharmaceuticals, Inc.
2091 Stierlin Court
Mountain View California 94303
P:(650) 944-7000
Investor Relations:

Employees

Shareholders

Individual stakeholders9.31%
Other institutional28.77%
Mutual fund holders16.99%

Top Executives

Thomas Braxton KingPresident, Chief Executive Officer & Director
Robert A. LippeChief Operations Officer & Executive VP-Operations
Mark K. OkiChief Financial Officer, Secretary, CAO & SVP
James V. CassellaCSO, Executive VP-Research & Development
Tatjana NarandaVP-Business Development & Alliance Management

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.